Paul B. Freeman OD, FAAO, FOVDR
Chief, Low Vision Rehabilitation Services, Allegheny General Hospital, Pittsburgh, Pennsylvania; Clinical Professor, University of the Incarnate Word, Rosenberg School of Optometry, San Antonio, TexasDr. Paul B. Freeman is the Chief of Low Vision Rehabilitation Services at Allegheny General Hospital in Pittsburgh, Pennsylvania, and he provides low vision rehabilitation services at Keystone Blind Association in Hermitage, Pennsylvania, and at Beaver County Association for the Blind in Conway, Pennsylvania. Dr. Freeman is also a Clinical Professor at the University of the Incarnate Word, Rosenberg School of Optometry in San Antonio, Texas.
Dr. Freeman’s clinical interests include visual impairment, traumatic brain injury, visual aspects of driving, and learning-related vision problems. He has been an investigator in a number of vision research projects to determine the efficacy of sophisticated low vision devices, to assess the psychological implications of low vision, and to explore the relationship of vision and the learning process.
A Fellow of the American Academy of Optometry and a Diplomate in Low Vision, Dr. Freeman is also a Fellow of Optometric Vision Development and Rehabilitation Association. He lectures both nationally and internationally and has authored numerous articles and book chapters. Currently, he is Editor-in-Chief of Optometric Clinical Practice.
Recent Contributions to PracticeUpdate:
- 2022 Top Story in Eye Care: Vision Impairment and Psychological Distress in Adults
- Outcomes of Eye-Tracking–Based Dichoptic Home Treatment in Children With Amblyopia
- Association Between Mental Health and Visual Acuity in Patients With AMD
- Telemedicine-Based Diabetic Retinopathy Screening Using AI-Based Image Analysis, Reflex Dilation, and Image Overread
- Application of Bifocal and Progressive Addition Lenses for Managing Accommodative Esotropia
- Comparison of Logarithmic Reading Charts for Visual Assessment
- AAPOS Uniform Guidelines for Instrument-Based Pediatric Vision Screen Validation 2021
- The 1969 Whole-Eye Transplant and Medical Ethics
- Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma
- Mileage and Collision Rate Prediction in Bioptic Drivers